BofA Securities Initiates Smith & Nephew(SNN.US) With Buy Rating
Buy Rating on Smith & Nephew: Turnaround, Growth, and Margin Improvement Prospects
Smith & Nephew (SN) Gets a Buy From RBC Capital
Barclays Sticks to Their Hold Rating for Smith & Nephew (SN)
Smith & Nephew (SN) Receives a Buy From UBS
RBC Capital Sticks to Its Buy Rating for Smith & Nephew (SN)
Smith & Nephew Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew Plc
Analysts Offer Insights on Healthcare Companies: Smith & Nephew Snats (SNN), Ocuphire Pharma (OCUP) and Vertex Pharmaceuticals (VRTX)
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew Plc
Balanced Outlook: Hold Rating Justified for Smith & Nephew Amidst Growth and Market Challenges
Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), TELA Bio (TELA) and Smith & Nephew Snats (SNN)
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew Plc
Smith & Nephew Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew
RBC Boosts Price Target on Smith & Nephew to GBP16 From GBP15, Keeps Outperform Rating
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew
Credit Suisse Cuts Price Target on Smith & Nephew to GBP14 From GBP15.40, Noting 'Mixed' First-Half Results, 'Major' Margin Pressure; Outperform Kept
No Data
No Data